Illinois Department of Public Health Chief Transformation Officer Massimo Pacilli discusses how the U.S. Disease Tracker is building a collaborative space for organizations to better public health.

Principal Deputy Assistant Secretary for Health and Director of National Health Communications in the Office of the Surgeon General, Stephanie Haridopolos, shares about the U.S. Surgeon General's new evidence-based toolkit on harmful screen use and the "Live Real Life" campaign.

In recognition of National Immunization Awareness Month, Michelle Fiscus, chief medical officer for the Association of Immunization Managers, shares about the current state of childhood immunization.

In this episode, we celebrate five years of Public Health Review: Morning Edition and revisit some of the defining moments from the podcast's past years.

On today's episode, ASTHO's Jeffrey Ekoma stops by for the View from Washington, D.C., highlighting Senate confirmations and the latest developments in FY27 appropriations.

Senior Analyst for Maternal and Infant Health at ASTHO Lexa Giragosian highlights ASTHO's latest research on implementing Levels of Maternal Care across the country, and how ASTHO has collaborated with 13 states to better maternal care.

Amy Ciarlo, senior analyst for Chronic Disease Risk Factors at ASTHO, highlights how fall prevention goes beyond clinical care and shares about programs like the CDC's STEADI program that aim to minimize fall risk.

In this PHIG Impact Report, Christina Floyd, deputy public health director for the Detroit Health Department, discusses how the city has used PHIG funding to strengthen their community and workforce.

Natasha Bagdasarian, chief medical executive for the State of Michigan and ASTHO member, highlights Michigan's Cyclospora outbreak and reflects on what can be learned from the state's response.

On today's bonus long-form episode, we hear from three public health experts as they highlight the Epidemiology and Laboratory Capacity (ELC) program and how it has become one of the nation's most important investments in infectious disease preparedness.